Radical new surgery aims to beat pancreatic Cancer's deadly complication
NCT ID NCT05116072
Summary
This study is testing a two-part surgery for certain pancreatic cancers. First, surgeons completely remove the pancreas to eliminate a dangerous complication called a fistula. Then, they transplant the patient's own insulin-producing cells into the liver to try to prevent severe diabetes. The goal is to see if this approach helps more patients safely finish their full course of cancer-fighting chemotherapy after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PANCREAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hop Claude Huriez Chu Lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.